Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis

BACKGROUND AND PURPOSE: Recombinant tissue plasminogen activator (rtPA) is the only effective drug approved by US FDA to treat ischemic stroke, and it contains pleiotropic effects besides thrombolysis. We performed a meta-analysis to clarify effect of tissue plasminogen activator (tPA) on cerebral i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Mei-Xue, Hu, Qing-Chuan, Shen, Peng, Pan, Jun-Xi, Wei, You-Dong, Liu, Yi-Yun, Ren, Yi-Fei, Liang, Zi-Hong, Wang, Hai-Yang, Zhao, Li-Bo, Xie, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936748/
https://www.ncbi.nlm.nih.gov/pubmed/27387385
http://dx.doi.org/10.1371/journal.pone.0158848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936748/
https://www.ncbi.nlm.nih.gov/pubmed/27387385
http://dx.doi.org/10.1371/journal.pone.0158848

Ejemplares similares